approved EB-1A
Associate Scientist
Immunotherapy · India · 2022-02-02
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Framework Evaluation
3 of 3 criteria metScholarly Articles (Met)
The petitioner published 6 peer-reviewed scientific articles in the field of immunotherapy.
Judging (Met)
The petitioner completed at least 19 peer reviews for respected journals, demonstrating recognition as an expert.
Original Contributions (Met)
The petitioner's research resulted in 1,088 citations and the discovery of unique anti-cancer drugs, signifying major significance to the field.
Why This Petition Was Approved
The petition was approved based on 6 peer-reviewed scientific articles and a high citation count of 1,088, demonstrating international appeal. Additionally, the petitioner's role in conducting 19 peer reviews for respected journals satisfied the judging criterion for EB-1A. Her work on unique anti-cancer drugs addressed pressing national health needs.
Evidence
Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Judging Experience
Original Contributions
Evidence Submitted
- 6 peer-reviewed scientific articles
- 1,088 citations
- 19 peer reviews for respected journals
- Discovery of unique anti-cancer drugs
- Four recommendation letters from expert scholars
Similar Cases
Research Scientist
Biotechnology · India
WeGreened EB-1A approved
Pennsylvania 3 days 2022-03-24
The petition was approved based on the petitioner's significant contributions to cancer immunotherapy, including 9 peer-reviewed scientific articles and 554 citations. She demonstrated her authority through 2 peer-review judging invitations and the filing of 1 patent and 2 patent applications. The case satisfied EB-1A criteria by showing her work is widely recognized and relied upon by researchers in at least 49 countries.
Research Fellow
Research and Development · China
WeGreened EB-1A approved
28 days 2023-05-23
The petitioner satisfied EB-1A criteria through 23 peer-reviewed scientific articles and 1 patent, which garnered 496 citations from researchers in 35 countries. Additionally, his expertise was recognized through 16 completed peer-review assignments for major international journals. His original contributions to medicinal chemistry and cancer research were validated by independent expert testimony.
Doctor
Healthcare · Taiwan
WeGreened EB-1A approved
Connecticut 14 days 2025-07-21
The petition was approved based on a substantial publication record of 33 peer-reviewed journal articles and 36 abstracts. The petitioner demonstrated global impact with 209 citations from researchers in 19 countries. Additionally, the case satisfied the judging criterion through 15 journal peer reviews and service on editorial boards.
Scientist
Healthcare · India
WeGreened EB-1A approved
Georgia 6 days 2024-07-31
The petition was approved based on a staggering 9,366 citations and a robust publication record including 9 peer-reviewed journal articles and 4 technical reports. The petitioner also demonstrated significant professional standing through 18 peer reviews of her peers' work. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.
Frequently Asked Questions
A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-02-02.
Browse all casesAt a Glance
Outcome approved
Processing 8 days
Criteria Met 3 / 3
Evidence Types 5
EB-1A Case Data
Scraped Case Data
Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist